A second-generation Covid-19 vaccine developed by CureVac and GlaxoSmithKline – designed to protect against coronavirus variants – produced a high level of immune response in a trial in rats, the companies said on May 13.
If you are not happy with the results below please do another search
50 search results for:
Merck announced positive results from the late-stage KEYNOTE-522 study for Keytruda as a neoadjuvant treatment for triple negative breast cancer, which should support the company’s previous attempt for U.S. approval that was stymied by a regulatory advisory committee in February and rejected by the Food and Drug Administration in March.
The Biden administration is releasing $7.4 billion to bolster the nation’s healthcare workforce amid the ongoing Covid-19 pandemic and to prepare for future epidemics and health challenges, the White House said in a statement on May 13.
Covid-19 vaccine developers are making ever bolder assertions that the world will need yearly booster shots, or new vaccines to tackle concerning coronavirus variants, but some scientists question when, or whether, such shots will be needed.
The U.S. Food and Drug Administration approved Heron Therapeutics Inc.’s Zynrelef (bupivacaine and meloxicam) extended-release solution for use in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after bunionectomy, open inguinal herniorrhaphy and total knee arthroplasty.
Giving a first dose of Covid-19 vaccine but delaying a second dose among people younger than 65 could lead to fewer people dying of the disease, but only if certain conditions are met, a predictive modelling study showed.
U.S. states are set to begin using the vaccine from Pfizer Inc. and BioNTech SE to inoculate young adolescents against Covid-19 after advisers to the U.S. Centers for Disease Control and Prevention (CDC) backed the plan in a unanimous vote on May 12.
United Nations Secretary-General Antonio Guterres called on May 12 for the need to double the capacity of Covid-19 vaccine production and for fairer redistribution of the shots in the developing world, which faces new waves of the coronavirus.
Nearly 40 percent of all global deaths from Covid-19 reported last week happened in the Americas, and nearly 80 percent of the region’s intensive care units are filled with Covid-19 patients, the Pan American Health Organization said on May 12.
Greater Than One (GTO) Group, a privately held, full-service global health and wellness marketing and communications agency network focused on providing clients with a unique framework of custom practice offerings, announced the launch of its newly designed website at https:///www.thegtogroup.com/. The new site features easy access to essential information on GTO Group’s unique offerings of GTO full-service agency, GTO Media, and GTO Enterprise.